Drawbridge Pharmaceuticals

Drawbridge Pharmaceuticals is a privately held company developing neuroactive steroid compounds for critical care. The characteristics of these compounds include anesthesia and sedation, anticonvulsant activity, and neuroprotection. Phaxan™, a leading compound, is a rapid onset and offset intravenous general anesthetic and sedative that protects the brain from the harmful effects of hypoxia and trauma.